ArticleCancers2022

Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial.

Selinde S Wind et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.